Xencor, Inc Variable Lease, Cost
Xencor, Inc (XNCR) reported Variable Lease, Cost of $301.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-05
- Xencor, Inc variable lease, cost for the quarter ending 2026-06-30 was $301.00K, a 122.96% increase year-over-year.
- Xencor, Inc variable lease, cost for the quarter ending 2026-03-31 was $306.00K, a 0.65% decline year-over-year.
- Xencor, Inc variable lease, cost for the quarter ending 2025-12-31 was $376.00K, a 12.91% increase year-over-year.
- Xencor, Inc variable lease, cost for the quarter ending 2025-09-30 was $259.00K.
- Xencor, Inc variable lease, cost for fiscal 2025 was $1.08M, a 15.33% decline from fiscal 2024.
- Xencor, Inc variable lease, cost for fiscal 2024 was $1.27M, a 40.40% increase from fiscal 2023.
- Xencor, Inc variable lease, cost for fiscal 2023 was $906.00K, a 79.05% increase from fiscal 2022.
- Xencor, Inc variable lease, cost for fiscal 2022 was $506.00K, a 772.41% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $301.00K 10-Q · filed 2026-08-05 | $607.00K 10-Q · filed 2026-08-05 | $983.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.24M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $306.00K 10-Q · filed 2026-05-06 | $682.00K derived: sum of 2 quarters · filed 2026-05-06 | $941.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $635.00K derived: sum of 2 quarters · filed 2026-02-25 | $770.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.08M 10-K · filed 2026-02-25 |
| 2025-09-30 | $259.00K 10-Q · filed 2025-11-05 | $394.00K derived: sum of 2 quarters · filed 2026-08-05 | $701.00K 10-Q · filed 2025-11-05 | $1.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $135.00K 10-Q · filed 2026-08-05 | $443.00K 10-Q · filed 2026-08-05 | $776.00K derived: sum of 3 quarters · filed 2026-08-05 | $575.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $308.00K 10-Q · filed 2026-05-06 | $641.00K derived: sum of 2 quarters · filed 2026-05-06 | $440.00K derived: sum of 3 quarters · filed 2026-05-06 | $750.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $132.00K derived: sum of 2 quarters · filed 2026-02-25 | $442.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.27M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$201.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $109.00K derived: sum of 2 quarters · filed 2025-11-05 | $939.00K 10-Q · filed 2025-11-05 | $1.16M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $310.00K 10-Q · filed 2025-08-06 | $1.14M 10-Q · filed 2025-08-06 | $1.36M derived: sum of 3 quarters · filed 2026-02-25 | $1.59M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $830.00K 10-Q · filed 2025-05-07 | $1.05M derived: sum of 2 quarters · filed 2026-02-25 | $1.28M derived: sum of 3 quarters · filed 2026-02-25 | $1.50M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $221.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | $453.00K derived: sum of 2 quarters · filed 2026-02-25 | $672.00K derived: sum of 3 quarters · filed 2026-02-25 | $906.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $232.00K 10-Q/A · filed 2025-02-24 | $451.00K derived: sum of 2 quarters · filed 2025-02-24 | $685.00K 10-Q/A · filed 2025-02-24 | $904.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $219.00K 10-Q/A · filed 2025-02-24 | $453.00K 10-Q/A · filed 2025-02-24 | $672.00K derived: sum of 3 quarters · filed 2025-02-27 | $828.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $234.00K 10-Q/A · filed 2025-02-24 | $453.00K derived: sum of 2 quarters · filed 2025-02-27 | $609.00K derived: sum of 3 quarters · filed 2025-02-27 | $642.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $375.00K derived: sum of 2 quarters · filed 2025-02-27 | $408.00K derived: sum of 3 quarters · filed 2025-02-27 | $506.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $156.00K 10-Q · filed 2023-11-08 | $189.00K derived: sum of 2 quarters · filed 2023-11-08 | $287.00K 10-Q · filed 2023-11-08 | $302.00K derived: sum of 4 quarters · filed 2025-02-24 |
| 2022-06-30 | $33.00K 10-Q · filed 2023-08-03 | $132.00K 10-Q · filed 2023-08-03 | $146.00K derived: sum of 3 quarters · filed 2025-02-24 | $162.00K derived: sum of 4 quarters · filed 2025-02-24 |
| 2022-03-31 | $99.00K 10-Q · filed 2023-05-08 | $113.00K derived: sum of 2 quarters · filed 2025-02-24 | $129.00K derived: sum of 3 quarters · filed 2025-02-24 | $147.00K derived: sum of 4 quarters · filed 2025-02-24 |
| 2021-12-31 | $14.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $30.00K derived: sum of 2 quarters · filed 2025-02-24 | $48.00K derived: sum of 3 quarters · filed 2025-02-24 | $58.00K 10-K/A · filed 2025-02-24 |
| 2021-09-30 | $16.00K 10-Q · filed 2022-11-07 | $34.00K derived: sum of 2 quarters · filed 2022-11-07 | $44.00K 10-Q · filed 2022-11-07 | $65.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $18.00K 10-Q · filed 2022-08-03 | $28.00K 10-Q · filed 2022-08-03 | $49.00K derived: sum of 3 quarters · filed 2023-02-27 | $119.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $10.00K 10-Q · filed 2022-05-05 | $31.00K derived: sum of 2 quarters · filed 2023-02-27 | $101.00K derived: sum of 3 quarters · filed 2023-02-27 | $139.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $91.00K derived: sum of 2 quarters · filed 2023-02-27 | $129.00K derived: sum of 3 quarters · filed 2023-02-27 | $150.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $70.00K 10-Q · filed 2021-11-08 | $108.00K derived: sum of 2 quarters · filed 2021-11-08 | $129.00K 10-Q · filed 2021-11-08 | $143.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $38.00K 10-Q · filed 2021-08-04 | $59.00K 10-Q · filed 2021-08-04 | $73.00K derived: sum of 3 quarters · filed 2022-02-24 | $84.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $22.00K 10-Q · filed 2021-05-05 | $35.00K derived: sum of 2 quarters · filed 2022-02-24 | $46.00K derived: sum of 3 quarters · filed 2022-02-24 | $93.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $24.00K derived: sum of 2 quarters · filed 2022-02-24 | $71.00K derived: sum of 3 quarters · filed 2022-02-24 | $80.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $11.00K 10-Q · filed 2020-11-06 | $58.00K derived: sum of 2 quarters · filed 2020-11-06 | $67.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $47.00K 10-Q · filed 2020-08-05 | $57.00K 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |